Home

CLSI M69 will provide a summary of available serologic assays (both antigen and antibody detection methods) for select bacterial and mycobacterial, fungal, viral, and parasitic infectious agents. It will outline indications for use, general method considerations, performance characteristics, and limitations. ...

 12-01-2023  |  Reviewer or Advisor

CLSI MM29 will focus on effective strategies for communication and consultation with clinicians and test utilization management to facilitate the use of genetic test results to improve patient care and outcomes. This group is looking for volunteers with: · Experience as a genetics laboratory ...

 12-01-2023  |  Reviewer or Advisor

CLSI M35 will provide the minimum identification criteria that can be used to rapidly identify a limited number of organisms commonly isolated from patient specimens. This information can be used by any accredited medical microbiology laboratory that is limited to using reagents or other materials that ...

 01-01-2024  |  Reviewer or Advisor

CLSI H26 will provide information on portions of the life cycle of an automated multichannel hematology system. It will also provide guidance for validation, verification, calibration, quality assurance (QA), and quality control (QC) through standardized approaches to ensure good laboratory science and ...

 01-01-2024  |  Reviewer or Advisor

CLSI H43 will provide information on flow cytometric analysis of peripheral blood, bone marrow aspirate, tissue samples, and body fluids for proof or exclusion of hematologic neoplasms. Although the World Health Organization Classification of Hematolymphoid Tumors and the International Consensus Classification ...

 03-11-2024  |  Reviewer or Advisor